- Home
- RCKT vs AHRT Comparison
RCKT vs AHRT Comparison
Compare RCKT & AHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.70
Company Overview
Basic Information| Metric | RCKT | AHRT |
|---|---|---|
| Founded | 1999 | 1979 |
| Country | United States | United States |
| Employees | 202 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 534.2M | 498.7M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | RCKT | AHRT |
|---|---|---|
| Price | $3.70 | $5.14 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 1 |
| Target Price | ★ $29.65 | $7.00 |
| AVG Volume (30 Days) | ★ 3.2M | 1.9M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.51% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $840.79 |
| Revenue Next Year | $51.17 | $10.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.19 | $5.30 |
| 52 Week High | $8.26 | $6.11 |
Technical Indicators
Market Signals| Indicator | RCKT | AHRT |
|---|---|---|
| Relative Strength Index (RSI) | 39.55 | 28.97 |
| Support Level | $2.91 | N/A |
| Resistance Level | $4.08 | $5.98 |
| Average True Range (ATR) | 0.38 | 0.24 |
| MACD | -0.11 | -0.06 |
| Stochastic Oscillator | 4.70 | 2.56 |
Price Performance
Historical Comparison RCKT
AHRT
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.